The Claim
In children diagnosed with Graves' disease, a larger thyroid volume at diagnosis is associated with a lower likelihood of achieving sustained remission following antithyroid drug therapy.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Children with Graves' disease who have a larger thyroid gland at diagnosis are less likely to achieve long-term remission after taking antithyroid drugs.
See the scientific wording
In children with Graves' disease, larger thyroid volume at diagnosis is associated with a lower likelihood of achieving sustained remission after antithyroid drug therapy, indicating that gland size may reflect disease severity or resistance to treatment.
A larger thyroid has more hormone-producing cells that make too much thyroid hormone and block the medicine from working well, making it harder to stop the disease permanently.
What the research says
1 studyStudy: The role of the FT3/FT4 ratio in predicting remission and relapse in pediatric Graves’ disease
Kids with Graves' disease who have a bigger thyroid when they're first diagnosed are less likely to stay healthy after stopping their medicine, and this study shows that bigger thyroid size means the disease is harder to cure with drugs alone.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.